ArticleOphthalmology science2026

OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.

Mai Alhelaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.